Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Hayden

Showing results (311-320 of 391) with videos related to

Pageof 40
Sort By:
The Journal of Infectious Diseases|December 12, 2019
Comparative Effectiveness of Combined Favipiravir and Oseltamivir Therapy Versus Oseltamivir Monotherapy in Critically Ill Patients With Influenza Virus InfectionYeming Wang, Guohui Fan, Alex Salam, et al.
Journal of Neuro-Oncology|September 13, 2013
Neuropilin-2 contributes to tumorigenicity in a mouse model of Hedgehog pathway medulloblastomaMelanie G Hayden Gephart, YouRong Sophie Su, Samuel Bandara, et al.
Antimicrobial Agents and Chemotherapy|November 26, 2003
Phase II, randomized, double-blind, placebo-controlled studies of ruprintrivir nasal spray 2-percent suspension for prevention and treatment of experimentally induced rhinovirus colds in healthy volunteersFrederick G Hayden, Ronald B Turner, Jack M Gwaltney, et al.
Antiviral Research|July 10, 2002
The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivoJ A L Ives, J A Carr, D B Mendel, et al.
JAMA|October 12, 1999
Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatmentF G Hayden, J J Treanor, R S Fritz, et al.
Antiviral Research|April 1, 1995
Antiviral resistance in clinical practiceD W Kimberlin, C S Crumpacker, S E Straus, et al.
JAMA|April 12, 2007
Safety and immunogenicity of a baculovirus-expressed hemagglutinin influenza vaccine: a randomized controlled trialJohn J Treanor, Gilbert M Schiff, Frederick G Hayden, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 13, 2003
Efficacy and safety of oral pleconaril for treatment of colds due to picornaviruses in adults: results of 2 double-blind, randomized, placebo-controlled trialsFrederick G Hayden, Darrell T Herrington, Teresa L Coats, et al.
Antimicrobial Agents and Chemotherapy|June 28, 2006
Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their useArnold S Monto, Jennifer L McKimm-Breschkin, Catherine Macken, et al.
Neurosurgery|February 1, 2022
In Reply: A Novel Protocol for Reducing Intensive Care Utilization After CraniotomyArjun V Pendharkar, Maryam N Shahin, Sohun S Awsare, et al.
Pageof 40

Showing results (311-320 of 391) with videos related to

Sort By:
Pageof 40
The Journal of Infectious Diseases|December 12, 2019
Comparative Effectiveness of Combined Favipiravir and Oseltamivir Therapy Versus Oseltamivir Monotherapy in Critically Ill Patients With Influenza Virus InfectionYeming Wang, Guohui Fan, Alex Salam, et al.
Journal of Neuro-Oncology|September 13, 2013
Neuropilin-2 contributes to tumorigenicity in a mouse model of Hedgehog pathway medulloblastomaMelanie G Hayden Gephart, YouRong Sophie Su, Samuel Bandara, et al.
Antimicrobial Agents and Chemotherapy|November 26, 2003
Phase II, randomized, double-blind, placebo-controlled studies of ruprintrivir nasal spray 2-percent suspension for prevention and treatment of experimentally induced rhinovirus colds in healthy volunteersFrederick G Hayden, Ronald B Turner, Jack M Gwaltney, et al.
Antiviral Research|July 10, 2002
The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivoJ A L Ives, J A Carr, D B Mendel, et al.
JAMA|October 12, 1999
Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatmentF G Hayden, J J Treanor, R S Fritz, et al.
Antiviral Research|April 1, 1995
Antiviral resistance in clinical practiceD W Kimberlin, C S Crumpacker, S E Straus, et al.
JAMA|April 12, 2007
Safety and immunogenicity of a baculovirus-expressed hemagglutinin influenza vaccine: a randomized controlled trialJohn J Treanor, Gilbert M Schiff, Frederick G Hayden, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 13, 2003
Efficacy and safety of oral pleconaril for treatment of colds due to picornaviruses in adults: results of 2 double-blind, randomized, placebo-controlled trialsFrederick G Hayden, Darrell T Herrington, Teresa L Coats, et al.
Antimicrobial Agents and Chemotherapy|June 28, 2006
Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their useArnold S Monto, Jennifer L McKimm-Breschkin, Catherine Macken, et al.
Neurosurgery|February 1, 2022
In Reply: A Novel Protocol for Reducing Intensive Care Utilization After CraniotomyArjun V Pendharkar, Maryam N Shahin, Sohun S Awsare, et al.
Pageof 40